Loading Events

« All Events

  • This event has passed.

BioNJ’s Finance Forum 2022

November 16 @ 8:00 am - 11:30 am

BioNJ’s Finance Forum is Eligible for 2 CPE Credits!*

Riding the Tumultuous Tide and Weathering the Storm: An Update from the Experts
Wednesday, November 16, 2022 | 8:00 a.m. – 11:30 a.m.
PwC, 400 Campus Drive, Florham Park, NJ 07932

Despite strong industry fundamentals and a rich late-stage clinical pipeline, the economy has been challenging for the industry. In an effort to shed light on what’s transpired and what’s to come, at this meeting, you’ll…

  • Acquire insights into this tumultuous market, including what’s happening to valuations and the IPO window.
  • Formulate an understanding of supply chain disruption and when some level of normalcy might be realized.
  • Analyze the challenges of vying for talent in a tight market.
  • Realize a perspective of the growing pressures around access and affordability and how the Inflation Reduction Act will affect that.
  • Examine the capital markets and macro economic trends with an update on the equity and debt funding environment.

Who should attend: 
Private and Public Company Controllers, Vice Presidents of Finance, CFOs, R&D Company CEOs, Finance Team Members and Legal Counsel and Others who are interested in the life sciences ecosystem.

Check Out the Agenda:
8:30 a.m. – 8:30 a.m.
Registration & Networking Breakfast
8:30 a.m. – 8:40 a.m.
Welcome from BioNJ & PwC
8:40 a.m. – 9:10 a.m.
Navigating the Uncertain Biotech Industry
Beyond Borders, the 2022 EY biotechnology report, is a deep dive into the state of the industry. From financing to deal making, financial performance and more, EY’s Beyond Borders offers insights to navigate today’s uncertainty. This session includes key considerations for industry leaders as they map a path forward and shares how:
  • The financial environment for biotech has significantly shifted in the opening months of 2022, with valuations plunging and the IPO window closing.
  • Biotechs are also facing new challenges around supply chain disruption, competition for talent, established commercial models and growing pressures around access and affordability.
  • Despite this, the industry’s fundamentals remain strong, with growing R&D spend supporting a rich late-stage clinical pipeline that likely will remain a key driver for the biopharma industry.
Speaker: Arda Ural, Ph.D., Americas Industry Markets Leader, Health Sciences and Wellness, EY
9:10 a.m. – 9:45 a.m.
Overview of Emerging Legislative, Tax and Accounting Updates
Presented by: Loral De Salvio, Director, PwC; Jeroen van Paassen, Partner, PwC; Anthony DiGiacinto, Director, EisnerAmper & Adam Firestone, Manager, EisnerAmper
9:45 a.m. – 10:00 a.m. Networking Break
10:00 a.m.– 11:00 a.m.
Capital Markets / Macro Economic Update
This informative session will provide a current update on the equity and debt funding environment, with commentary from the head of healthcare investment banking at Cantor Fitzgerald and a portfolio manager of a healthcare lender, Perceptive Advisors, complemented by an economist from PwC — all providing perspectives and advice on recent select transactions and a glimpse into the remainder of 2022 and the upcoming year.
Steve Aldridge, Managing Director, Healthcare Investment Banking, Cantor Fitzgerald & Co.
Nataly Yackanich, Director & Lead FS Analyst, PwC Intelligence, PwC US
Sam Chawla, Portfolio Manager, Credit, Perceptive Advisors
Moderated by: Brian Lenz, Executive Vice President & Chief Financial Officer, ADMA Biologics
11:00 a.m. – 11:30 a.m. Networking

Registration is open to BioNJ Innovation (R&D) Company Member Professionals, as well as Market Maker, Preferred, Executive level and Institution BioNJ Members. Future BioNJ Innovation Member fee is $50. Click here to register.

Thank You to Our Host Sponsor Thank You to Our CPE Sponsor

Out of consideration for the health and wellbeing of our community, we ask that you please attend only if:

  • You are up to date on COVID-19 vaccinations.
  • You are not experiencing or exhibiting any COVID-19 related symptoms as outlined by the federal and state CDC, such as fever, dry cough, fatigue, muscle aches, headache, loss of taste or smell, sore throat, nasal congestion or shortness of breath.
  • You tested positive for COVID-19, at least 5 days have passed and have a received a negative COVID-19 test result from an FDA-approved or authorized COVID-19 viral (not antibody) test and resolution of any COVID-19-related symptoms.
  • You traveled internationally within the last 10 days, you have received a negative COVID-19 test result 3-5 days after arrival in the U.S.
  • You will follow the safety protocols that have been implemented by BioNJ and the event venue.

*Eisner Advisory Group LLC is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org.

NASBA Sponsor Registry ID: 108139.


November 16
8:00 am - 11:30 am
Event Category:


400 Campus Drive
Florham Park, NJ 07932 United States
+ Google Map